This result is consistent with the lack of anti-proliferation activities of the other two CARM1 chemical probes, EZM2302 and TP-064, against breast cancer cell lines (Drew et al., 2017; Nakayama et al., 2018). This evidence concerns the gene CARM1 and breast cancer.